Evaluation of cardiovascular risk by growth-differentiation factor-15 and tissue Doppler imaging in children with subclinical hypothyroidism

被引:5
|
作者
Arslan, Derya [1 ]
Buyukinan, Muammer [2 ]
Uysal, Celil [3 ]
Deniz, Cigdem Damla [4 ]
机构
[1] Konya Training & Res Hosp, Univ Hlth Sci, Dept Pediat Cardiol, Konya, Turkey
[2] Konya Training & Res Hosp, Dept Pediat Endocrinol, Konya, Turkey
[3] Patnos State Hosp, Dept Pediat, Agri, Turkey
[4] Konya Training & Res Hosp, Dept Biochem, Konya, Turkey
关键词
Subclinical hypothyroidism; Cardiovascular risk; GDF-15; Child; HEART-FAILURE; GUIDELINES; ECHOCARDIOGRAPHY; ASSOCIATION; CHILDHOOD; HORMONE; DISEASE;
D O I
10.1007/s12020-019-01933-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Subclinical hypothyroidism, defined as increased TSH serum levels and normal serum free T4 concentrations, has been associated with an increased risk of heart disease in adults. But, data in children and adolescents are scanty and treatment of subclinical hypothyroidism is controversial. Growth differentiation factor-15 (GDF-15) is a promising biomarker of cardiac remodeling. This study aimed to evaluate the cardiovascular risk factors in children with subclinical hypothyroidism, measured with tissue Doppler echocardiography (TDE), and conventional echocardiography and GDF-15 level. Methods The study comprised a total of 41 pediatric patients with subclinical hypothyroidism (SH) (mean age 9.6 +/- 4.7 years) and 31 healthy children (mean age 11.2 +/- 3.4 years) as the control group. Subclinical hypothyroidism was defined as a thyroid-stimulating hormone level higher than 4 mIU/l and a normal free-thyroxine level (0.6-1.8 ng/dl). Tissue Doppler echocardiography was performed to all individuals in the control group and patient group at the beginning of the study. Global systolic function as assessed by left ventricular ejection fraction was compared between groups. The serum GDF-15 level was measured. Results There were no significant differences in demographic parameters between the SH and control groups. The left ventricular internal diameter end systole, interventricular septal end diastole, left ventricular posterior wall end diastole, and tricuspid annular plane systolic excursion values were significantly different between the SH and control groups (p = 0.038, 0.028, 0.005, and 0.000, respectively). The mean mitral isovolumic relaxation time value of the SH group was 57.2 +/- 9.3 ms, compared to 44.5 +/- 5.6 ms for the control group (p = 0.000). The mean tricuspid isovolumic contraction time value of the SH group was 58.7 +/- 9.4 ms, and that of the control group was 45.1 +/- 5.3 ms (p = 0.000). The mean tricuspid isovolumic relaxation time value of the SH group was 58.03 +/- 9.5 ms, and that of the control group was 45.1 +/- 5.3 ms (p = 0.000). There were no significant differences in the other m-mode or pulse Doppler echocardiography values between two groups. The GDF-15 value of the SH group was 382.6 +/- 268.2 pg/mL, and that of the control group was 473.6 +/- 337.9 pg/mL; this difference was not significant. Conclusion Patients with subclinical hypothyroidism versus healthy individuals had some changes in echocardiographic parameters that indicate involvement of diastolic function of the left ventricle. They were significantly different when compared SH group and the control group. This study demonstrated ventricle diastolic dysfunction in pediatric patients with hypothyroidism. The results of our study suggest that cardiac follow-up may be useful in patients with subclinical hypothyroidism and clinical trials are needed to explore therapeutic effects of T4 and T3 administration in this patients.
引用
收藏
页码:601 / 607
页数:7
相关论文
共 50 条
  • [21] Epidermal growth factor, growth differentiation factor-15, and survivin as novel biocompatibility markers in children on chronic dialysis
    Bargenda, Agnieszka
    Musial, Kinga
    Zwolinska, Danuta
    BIOMARKERS, 2016, 21 (08) : 752 - 756
  • [22] The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese Patients
    Vila, Greisa
    Riedl, Michaela
    Anderwald, Christian
    Resl, Michael
    Handisurya, Ammon
    Clodi, Martin
    Prager, Gerhard
    Ludvik, Bernhard
    Krebs, Michael
    Luger, Anton
    CLINICAL CHEMISTRY, 2011, 57 (02) : 309 - 316
  • [23] Repeated measurement of growth-differentiation factor-15 in Chinese Han patients with post-myocardial infarction chronic heart failure
    Liu, Ji-Xuan
    Li, Yan-Ping
    Liu, Bo-Han
    Zhao, Xiao-Jing
    Zhang, Ze-Yu
    Wang, Jin-Da
    Jia, Qian
    Liu, Chun-Lei
    Gao, Xiao-Jian
    Xu, Zhen-Guo
    Zhang, Hua-Wei
    Song, Lin-Nan
    Sun, Zhi-Jun
    He, Kun-Lun
    JOURNAL OF GERIATRIC CARDIOLOGY, 2018, 15 (10) : 618 - 627
  • [24] Serial Measurement of Growth-Differentiation Factor-15 in Heart Failure Relation to Disease Severity and Prognosis in the Valsartan Heart Failure Trial
    Anand, Inder S.
    Kempf, Tibor
    Rector, Thomas S.
    Tapken, Heike
    Allhoff, Tim
    Jantzen, Franziska
    Kuskowski, Michael
    Cohn, Jay N.
    Drexler, Helmut
    Wollert, Kai C.
    CIRCULATION, 2010, 122 (14) : 1387 - +
  • [25] Growth differentiation factor-15 in patients with or at risk of heart failure but before first hospitalisation
    Bradley, Joshua
    Schelbert, Erik B.
    Bonnett, Laura J.
    Lewis, Gavin A.
    Lagan, Jakub
    Orsborne, Christopher
    Brown, Pamela Frances
    Black, Nicholas
    Naish, Josephine H.
    Williams, Simon G.
    McDonagh, Theresa
    Schmitt, Matthias
    Miller, Christopher A.
    HEART, 2024, 110 (03) : 195 - 201
  • [26] Growth Differentiation Factor-15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J-HOP Study
    Negishi, Keita
    Hoshide, Satoshi
    Shimpo, Masahisa
    Kanegae, Hiroshi
    Kario, Kazuomi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (24):
  • [27] Circulating Level of the Growth-Differentiation Factor-15 Is Increased in Dogs With Heart Failure and Normalized After Long-term Therapy With Elamipretide
    Sabbah, Hani N.
    Gupta, Ramesh C.
    Singh-Gupta, Vinita
    Zhang, Kefei
    Xu, Jiang
    CIRCULATION, 2016, 134
  • [28] Evaluation of the relation between subclinical systolic dysfunction defined by four-dimensional speckle-tracking echocardiography and growth differentiation factor-15 levels in patients with acromegaly
    Firlatan, Busra
    Karakulak, Ugur Nadir
    Hekimsoy, Vedat
    Iremli, Burcin Gonul
    Lay, Incilay
    Yuce, Deniz
    Dagdelen, Selcuk
    Kabakci, Giray
    Erbas, Tomris
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2024, 23 (04): : 777 - 788
  • [29] Circulating Level of the Growth-Differentiation Factor-15 Is Increased in Dogs With Heart Failure and Normalized After Long-term Therapy With Elamipretide
    Sabbah, Hani N.
    Gupta, Ramesh C.
    Singh-Gupta, Vinita
    Zhang, Kefei
    Xu, Jiang
    CIRCULATION, 2016, 134
  • [30] Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis
    Kato, Eri Toda
    Morrow, David A.
    Guo, Jianping
    Berg, David D.
    Blazing, Michael A.
    Bohula, Erin A.
    Bonaca, Marc P.
    Cannon, Christopher P.
    de Lemos, James A.
    Giugliano, Robert P.
    Jarolim, Petr
    Kempf, Tibor
    Newby, L. Kristin
    O'Donoghue, Michelle L.
    Pfeffer, Marc A.
    Rifai, Nader
    Wiviott, Stephen D.
    Wollert, Kai C.
    Braunwald, Eugene
    Sabatine, Marc S.
    EUROPEAN HEART JOURNAL, 2023, 44 (04) : 293 - +